Assert-IQ vs Irregular Rhythm Notification Feature (IRNF)

Tool B (Irregular Rhythm Notification Feature) is integrated into a widely adopted consumer device (Apple Watch) and iPhone, offering over-the-counter availability and ease of use for the general public. Tool A (Assert-IQ) requires a minimally invasive insertion procedure performed by a healthcare professional, making it less immediately accessible and user-friendly for the patient.

Tool A (Assert-IQ) provides long-term continuous cardiac monitoring for up to six years with advanced arrhythmia detection algorithms, designed for comprehensive diagnosis and management by physicians. Tool B (IRNF) is a screening feature that suggests irregular rhythms indicative of AFib, empowering users to discuss with their doctors, but it does not offer the same depth of continuous diagnostic data or monitoring duration as a dedicated insertable cardiac monitor.

Tool B (Irregular Rhythm Notification Feature) is included with the purchase of an Apple Watch, offering significant value as an additional health feature without extra cost. Tool A (Assert-IQ) is an enterprise-priced medical device, requiring institutions to contact Abbott Medical for specific pricing, indicating a substantially higher cost and a different purchasing model.

Tool A (Assert-IQ) is explicitly designed for large health systems, hospitals, and cardiology clinics, offering HIPAA compliance and a hybrid deployment model suitable for enterprise integration. Tool B (IRNF) is a consumer feature; while it encrypts data, Apple does not offer a Business Associate Agreement (BAA) for IRNF or HealthKit data, which is a critical requirement for healthcare providers handling Protected Health Information (PHI) within an enterprise setting.

While Tool A offers advanced long-term monitoring, Tool B (IRNF) demonstrates significant innovation by bringing an FDA-cleared, machine learning-based AFib screening tool to a mass-market consumer wearable. This democratizes early detection of potential AFib, making a medically relevant feature widely accessible to millions of users through a familiar device.

As an enterprise medical device, Tool A (Assert-IQ) from Abbott Medical would inherently come with comprehensive professional support, training, and detailed technical documentation tailored for clinicians and healthcare IT staff. Tool B (IRNF) relies on Apple's general consumer support ecosystem and in-app educational materials, which, while extensive, do not offer the same specialized clinical and technical support expected for a dedicated medical device used in a professional healthcare setting.